Home LiteratureArticle Details
PMID: 2496655 Published · ppublish English Journal Article

Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.

Antimicrobial agents and chemotherapy ·Vol. 33 ·No. 1 ·1989-01-00 ·Pages 124-7

Legakis NJ, Tzouvelekis LS, Makris A, Kotsifaki H

Abstract

Spontaneous mutants of Pseudomonas aeruginosa selected by ciprofloxacin were studied for outer membrane alterations. Acquisition of ciprofloxacin resistance was at least partially related to defects in lipopolysaccharide synthesis. When ciprofloxacin resistance was combined with resistance to beta-lactams and aminoglycosides, several alterations in outer membrane proteins were noted.

MeSH Terms
Bacterial Outer Membrane Proteins/metabolism Ciprofloxacin/pharmacology Drug Resistance, Microbial Pseudomonas aeruginosa/drug effects,metabolism,ultrastructure
Chemicals
Bacterial Outer Membrane Proteins Ciprofloxacin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Legakis N J
Department of Microbiology, School of Health Sciences, Goudi, Athens, Greece.
Tzouvelekis L S
Makris A
Kotsifaki H
References (25)
25 references, click to expand
  1. The nature of Pseudomonas aeruginosa strain PAO bacteriophage receptors.
    Can J Microbiol. 1977 Jun;23(6):653-8 PMID: 406024
  2. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
    Antimicrob Agents Chemother. 1988 Apr;32(4):535-9 PMID: 2837141
  3. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
    Antimicrob Agents Chemother. 1982 Dec;22(6):1037-41 PMID: 6218778
  4. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.
    J Bacteriol. 1983 Apr;154(1):269-77 PMID: 6187729
  5. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Eur J Clin Microbiol. 1983 Apr;2(2):111-5 PMID: 6222896
  6. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Antimicrob Agents Chemother. 1984 Mar;25(3):319-26 PMID: 6232895
  7. Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1984 Aug;26(2):181-6 PMID: 6435513
  8. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1984 Aug;26(2):250-5 PMID: 6207771
  9. Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa.
    Ann Microbiol (Paris). 1984 Sep-Oct;135B(2):121-36 PMID: 6439097
  10. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
    Antimicrob Agents Chemother. 1984 Dec;26(6):797-801 PMID: 6098219
  11. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.
    J Infect Dis. 1985 Mar;151(3):501-7 PMID: 2982966
  12. Molecular basis of bacterial outer membrane permeability.
    Microbiol Rev. 1985 Mar;49(1):1-32 PMID: 2580220
  13. Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
    Antimicrob Agents Chemother. 1988 May;32(5):785-7 PMID: 3134852
  14. Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin.
    J Infect Dis. 1985 Aug;152(2):351-5 PMID: 3928770
  15. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  16. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States.
    Antimicrob Agents Chemother. 1985 Aug;28(2):282-8 PMID: 3914858
  17. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Antimicrob Agents Chemother. 1986 Apr;29(4):639-44 PMID: 3010850
  18. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
    Antimicrob Agents Chemother. 1986 Mar;29(3):535-8 PMID: 3521490
  19. Distribution of porin and lipopolysaccharide antigens on a Pseudomonas aeruginosa permeability mutant.
    Antimicrob Agents Chemother. 1986 Nov;30(5):802-5 PMID: 3026242
  20. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1987 Apr;31(4):582-6 PMID: 3111356
  21. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.
    Antimicrob Agents Chemother. 1987 May;31(5):703-8 PMID: 3111361
  22. Importance of carbenicillin and gentamicin cross-resistant serotype 0:12 Pseudomonas aeruginosa in six Athens hospitals.
    Eur J Clin Microbiol. 1987 Jun;6(3):300-3 PMID: 3113940
  23. Norfloxacin resistance in a clinical isolate of Escherichia coli.
    Antimicrob Agents Chemother. 1987 Oct;31(10):1640-1 PMID: 2829712
  24. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
    Antimicrob Agents Chemother. 1987 Nov;31(11):1803-8 PMID: 3124739
  25. Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.
    J Clin Microbiol. 1982 Sep;16(3):458-63 PMID: 6813351
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1989-01-00
Pages
124-7
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC171437
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]